Medical News The Mainstream Media Won't Truthfully Show You

Patents By “Inventor” Anthony S. Fauci

“There will be a surprise outbreak…”

“There is no doubt in anyone’s mind that the new administration will be faced with the challenges that their predecessors were faced with.”

Hemagglutinin Esterase -COVID-19 Scare

Hemagglutinin esterase is a glycoprotein that certain enveloped viruses possess and use as invading mechanism. HEs helps in the attachment and destruction of certain sialic acid receptors that are found on the host cell surface. Viruses that possess HEs include Influenza C virus, toroviruses, and coronaviruses.

Dr Anthony Fauci patents — **1. Spike-Glycoprotein** (S) 2. M-Protein 3. Hemagglutinin-Esterase Dimer (HE) 4. Envelope 5. RNA and N Protein 6. E-Protein

1. Spike-Glycoprotein (S)
2. M-Protein
3. Hemagglutinin-Esterase Dimer (HE)
4. Envelope
5. RNA and N Protein
6. E-Protein

If there’s anybody that still doesn’t think the COVID-19 scare isn’t a False Flag, The spikes that come out of the Coronavirus, that make it attach inside the lungs are called Spike Glycoproteins or S-proteins for short. The COVID-19 virus has S-protein 120 spikes. S-protein 120 is only found in one other virus known to man, HIV. This shows that Covid-19 was genetically modified and weaponized by the insertion of these HIV proteins. Now everyone thinks they need to wear masks because of Anthony Fauci’s domestic terrorism.

Dr Anthony Fauci Patents

Look at the dates of the patents below and watch the very short video of Dr Fauci prophesying the “surprise outbreak”, which turned out to be COVID-19

Use of antagonists of the interaction between HIV GP120 and α4β7 integrin

Patent Number: 9896509
Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and α4β integrin, such as α4β1 or α4β7 integrin antagonist, thereby treating the HIV infection.

In several examples, the α4β integrin antagonist is a monoclonal antibody that specifically binds to a α4β4, α4β1 or α4β7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC. Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and α4β integrin, such as a α4β1 or α4β7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV.

Type: Grant
Filed: August 3, 2016
Date of Patent: February 20, 2018
Assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services
Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci

USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND A4B7 INTEGRIN

Publication Number: 20160333097
Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and α4β integrin, such as a α4β1 or α4β7 integrin antagonist, thereby treating the HIV infection. In several examples, the α4β integrin antagonist is a monoclonal antibody that specifically binds to a α4β, α4β1 or α4β7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC.

Methods are also provided to reduce HIV replication or infection. The methods include contacting a cell with an effective amount of an agent that interferes with the interaction of gp120 and α4β integrin, such as a α4β1 or α4β7 integrin antagonist. Moreover, methods are provided for determining if an agent is useful to treat HIV.

Type: Application
Filed: August 3, 2016
Publication Date: November 17, 2016
Applicant: THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Serv
Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci

Use of antagonists of the interaction between HIV GP120 and α4β7 integrin
Patent Number: 9441041
Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and α4β integrin, such as a α4β1 or α4β7 integrin antagonist, thereby treating the HIV infection. In several examples, the α4β integrin antagonist is a monoclonal antibody that specifically binds to a α4β, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC.

Type: Grant
Filed: September 21, 2015
Date of Patent: September 13, 2016
Assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services
Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci

USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND A4B7 INTEGRIN

Publication Number: 20160075786
Abstract: Methods are provided for the treatment of a HIV infection. The methods can include administering to a subject with an HIV infection a therapeutically effective amount of an agent that interferes with the interaction of gp120 and α4β integrin, such as a α4β1 or α4β7 integrin antagonist, thereby treating the HIV infection. In several examples, the α4β integrin antagonist is a monoclonal antibody that specifically binds to a α4β, ?1 or ?7 integrin subunit or a cyclic hexapeptide with the amino acid sequence of CWLDVC.

Type: Application
Filed: September 21, 2015
Publication Date: March 17, 2016
Applicant: The United States of America, as Represented by the Secretary, Department of Health and Human Serv
Inventors: James Arthos, Diana Goode, Claudia Cicala, Anthony S. Fauci

IMMUNOCONJUGATES COMPRISING CD4 AND IMMUNOGLOBIN MOLECULES FOR THE TREATMENT OF HIV INFECTION

Publication Number: 20090285815
Abstract: Nucleic acids encoding recombinant CD4-fusion proteins are disclosed herein that include a CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin comprising a hinge region and a constant domain of a mammalian immunoglobulin heavy chain.

The portion of the IgG is fused at its C-terminus with a polypeptide comprising a tailpiece from the C terminus of the heavy chain of an IgA antibody or a tailpiece from a C terminus of the heavy chain of an IgM antibody. Also disclosed herein are methods for using these CD4-fusion proteins.
Type: Application
Filed: March 21, 2008
Publication Date: November 19, 2009
Inventors: James Arthos, Claudia Cicala, Anthony S. Fauci

Fusion protein including of CD4

Patent Number: 7368114
Abstract: Novel recombinant polypeptides are disclosed herein that include a CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin comprising a hinge region and a constant domain of a mammalian immunoglobulin heavy chain.

The portion or the IgG is fused at its C-terminus with a polypeptide comprising a tailpiece from the C-terminus of the heavy chain of an IgA antibody ara tailpiece from a C-terminus of the heavy chain of an IgM antibody. Also disclosed herein are methods for using these CD4 fusion proteins.
Type: Grant
Filed: October 24, 2002
Date of Patent: May 6, 2008
Assignee: The United States of America as represented by the Department of Health and Human Services
Inventors: James Arthos, Claudia Cicala, Anthony S. Fauci

HIV related peptides

Patent Number: 6911527
Abstract: This invention is the discovery of novel specific epitopes and antibodies associated with long term survival of HIV-1 infections. These epitopes and antibodies have use in preparing vaccines for preventing HIV-1 infection or for controlling progression to AIDS.
Type: Grant
Filed: January 7, 2000
Date of Patent: June 28, 2005
Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
Inventors: Giuseppe Scala, Xueni Chen, Oren J. Cohen, Anthony S. Fauci

Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4

Publication Number: 20040265306
Abstract: Novel recombinant polypeptides are disclosed herein that include a CD4 polypeptide ligated at its C-terminus with a portion of an immunoglobulin comprising a hinge region and a constant domain of a mammalian immunoglobulin heavy chain. The portion of the IgG is fused at its C-terminus with a polypeptide comprising a tailpiece from the C-terminus of the heavy chain of an IgA antibody or a tailpiece from a C-terminus of the heavy chain of an IgM antibody. Also disclosed herein are methods for using these CD4-fusion proteins.
Type: Application
Filed: July 27, 2004
Publication Date: December 30, 2004
Inventors: James Arthos, Claudia Cicala, Anthony S. Fauci

Immunologic enhancement with intermittent interleukin-2 therapy
Publication Number: 20030180254
Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value.

This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy.
Type: Application
Filed: January 23, 2003
Publication Date: September 25, 2003
Applicant: The Govt. of the USA as represented by the Secretary of the Dept. of Health & Human Services
Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci

Immunologic enhancement with intermittent interleukin-2 therapy
Patent Number: 6548055
Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value.

This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy.
Type: Grant
Filed: August 9, 2000
Date of Patent: April 15, 2003
Assignee: The United States of America as represented by the Department of Health and Human Services
Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci

Immunologic enhancement with intermittent interleukin-2 therapy
Patent Number: 6190656
Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value.

This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy.
Type: Grant
Filed: September 2, 1997
Date of Patent: February 20, 2001
Assignee: The United States of America as represented by the Department of Health and Human Services
Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci

Immunologic enhancement with intermittent interleukin-2 therapy
Patent Number: 5696079
Abstract: A method for activating a mammalian immune system entails a series of IL-2 administrations that are effected intermittently over an extended period. Each administration of IL-2 is sufficient to allow spontaneous DNA synthesis in peripheral blood or lymph node cells of the patient to increase and peak, and each subsequent administration follows the preceding administration in the series by a period of time that is sufficient to allow IL-2 receptor expression in peripheral or lymph node blood of the patient to increase, peak and then decrease to 50% of peak value.

This intermittent IL-2 therapy can be combined with another therapy which targets a specific disease state, such as an anti-retroviral therapy comprising, for example, the administration of AZT, ddI or interferon alpha. In addition, IL-2 administration can be employed to facilitate in situ transduction of T cells in the context of gene therapy.
Type: Grant
Filed: May 26, 1995
Date of Patent: December 9, 1997
Assignee: The United States of America as represented by the Department of Health and Human Services
Inventors: H. Clifford Lane, Joseph A. Kovacs, Anthony S. Fauci

Dr Anthony Fauci Prophesying A Surprise Outbreak During President Trump’s Administration!

The Dr Fauci 2017 pandemic video from his keynote address at Georgetown University on Pandemic Preparedness 2017 and how President Trump will have to deal with a “surprise outbreak”. Would that surprise outbreak have anything to do with one of the patents you have for the virus YOU, Dr Fauci, created and like the HIV virus, YOU, Dr Fauci, let spread around the world!!??

Dr Anthony Fauci, Prophesying A Surprise Outbreak!!

Gilead Sciences, Owned By George Soros And Financed By Bill & Melinda Foundation

You’ll never guess who the main financial investors in UNITAID are….none other than George Soros, Bill & Melinda Gates, and WHO

George, Bill & Melinda, Sitting in a Tree, M-O-R-E Money For The Three

George, Bill & Melinda, Sitting In A Tree, The One They’ll Hang From Yes, Indeed

Which do you like better, the first heading or the second? Leave a comment and tell me whichYou’ll NEVER guess who owns Gilead Sciences? It’s just an interesting coincidence that Remdesivir is made by Gilead and is the “CURE” for COVID-19….and here’s where it gets interesting China holds the patent on the drug through an agreement with Gilead’s drug patent sharing subsidiary branch called UNITAID who has an office near Wuhan

Remdesivir Gallows For Soros, Bill and Melinda — **Gallows For George Soros, Bill and Melinda Gates**

You’ll never guess who the main financial investors in UNITAID are….none other than George Soros, Bill & Melinda Gates, and WHO. I know what your thinking! It’s just all a coincidence isn’t it! Oh, don’t let me forget the other coincidence that Gilead and UNITAID were financial supporters of Hillary Clinton.

George Soros, Bill & Melinda Gates 666 — **I was Writing The Title For This Page And Then Noticed The Character Count**

I noticed that 666 and had to change it, after I changed it, I noticed my total word count for this article, 1111.

One more coincidence Fauci was the one authorizing millions to be sent to The Wuhan Institute of Virology specifically for the “study” of Coronaviruses……I sure am thankful it’s all just coincidences! Nothing to see here just keep moving along….WOW! No wonder Fauci slapped down hydroxychloroquine which has a 92% success rate…he was told to!! The Best Coincidences are always found when you follow the money trail.

From The Unitaid Website

Unitaid is an international organization that invests in innovations to prevent, diagnose and treat HIV/AIDS, tuberculosis and malaria more quickly, affordably and effectively. We also work to improve access to diagnostics and treatment for HIV co-infections such as hepatitis C and human papillomavirus (HPV). Unitaid is a hosted partnership of the World Health Organization (WHO).

Since its establishment in 2006, Unitaid has received about US $3 billion in contributions from donors. Unitaid’s main donors are France, the United Kingdom, Norway, the Bill & Melinda Gates Foundation, Brazil, Spain, the Republic of Korea, and Chile.

As drug manufacturers speed up their efforts to find a new treatment drug for the coronavirus outbreak that has devastated China and has caused a world-wide panic, a Chinese drug company mid February announced that it has started mass-producing an experimental drug from Gilead Sciences that has the potential to fight the novel coronavirus.

Is China Stealing ‘Intellectual’ Property Again?

BrightGene Bio-Medical Technology, a Suzhou based company, just announced that it has developed the technology to synthesize the active pharmaceutical ingredients of Remdesivir, the drug developed by Gilead Biosciences. Its stock price surged 20% in Tuesday morning trading in Shanghai.

“While BrightGene said that it intends to license the drug from Gilead, its move to start manufacturing at this early stage is highly unusual and a potential infringement of the American company’s intellectual property.“ This comes a week after Chinese researchers at the Wuhan Institute of Virology filed an application to patent Gilead’s drug Remdesivir to treat the new coronavirus, a bid that would give China leverage over the global use of the therapy to fight the outbreak.

The decision to seek a patent instead of invoking a “compulsory license” option that lets nations override drug patents in national emergencies, signals China’s commitment toward intellectual property rights.

The timing is uncanny! Right? Gilead will retain the global rights to market the antiviral medication, once approved. Gilead has also announced that it is partnering with the Chinese Health Authorities on the clinical trials of Remdesivir as a treatment for coronavirus.

Ebola Virus Particles - Hydroxychloroquine — **Ebola Virus Particles**

Remdesivir was originally developed in 2016 by Gilead as a treatment for the Ebola virus (another virus made by the same people and Hydroxychloroquine is good for that too!). Many have argued that China stole the patent from Gilead due to a technicality, but you will soon see that this is indeed not the case.

And who exactly is Gilead Biosciences? Gilead is partnered with Wuxi Pharmaceuticals (Wuxi AppTec) owned by New World Order philanthropist and mass manipulator himself, George Soros! Here is a printout of Soros Fund Managaement Portfolio which will confirm this!

soros companies — **Look at that address: 666 Gaoxin Road East Lake High-Tech Development Zone, Wuhan China**

Look at that address number 666…that’s just a coincidence. There is no such thing as coincidence!

The Food and Drug Administration on Friday granted emergency use authorization for Gilead’s drug to treat Covid-19 after the National Institute of Allergy and Infectious Diseases released results from its clinical trial showing patients who took remdesivir usually recovered after 11 days, four days faster than those who didn’t take the drug. (4 days faster, but forever in need of vaccinations. The ones who didn’t take it RECOVERED PERMANENTLY! Their immune systems have built an immunity. DO NOT GET VACCINATED FOR SOMETHING YOUR OWN IMMUNE SYSTEM WILL TAKE CARE OF.

Soros, Gates, Fauci And The Clintons Are Involved

Unitaid is a global health initiative that works with partners to bring about innovations to prevent, diagnose and treat major diseases in low- and middle-income countries, with an emphasis on tuberculosis, malaria, and HIV/AIDS and its deadly co-infections.

Founded in 2006, the organization funds the final stages of research and development of new drugs, diagnostics and disease-prevention tools, helps produce data supporting guidelines for their use, and works to allow more affordable generic medicines to enter the marketplace in low- and middle-income countries. Hosted by the World Health Organization (WHO) in Geneva, Unitaid was established by the governments of Brazil, Chile, France, Norway and the United Kingdom.

I bet they are using the HIV medicine that Dr Judy Mikovits created.

As of 2019, Unitaid manages a portfolio of 48 grants worth around US$1.3 billion. More than half of Unitaid’s projects contribute to the global fight against antimicrobial resistance.

Unitaid supports programs that are implemented by organizations such as Coalition Plus, the Clinton Health Access Initiative, Elizabeth Glaser Pediatric AIDS Foundation, Expertise France, The Global Fund, Foundation for Innovative New Diagnostics, Médecins Sans Frontières, Medicines for Malaria Venture, Stop TB Partnership,TB Alliance, UNICEF and others.

Snopes Says This Is False, So It Must Be True

Is a Global Conspiracy Promoting Remdesivir Over Hydroxychloroquine for Treating COVID-19?

A sprawling conspiracy theory holds that numerous individuals and organizations schemed to promote Remdesivir over a drug that the U.S. president has touted.

Covid-19: Gilead’s Remdesivir May Reduce Sperm Count and Increase Abnormalities in Mice, Shows Chinese Study

Wow, weird how the “cure” for COVID-19 is also a cure for the population “problem”! George Soros, Bill and Melinda Gates and the Clintons are to be praised, not scorned. Since they are offering a cure for COVID 19 or as they are calling it now, 2019-nCoV, their involvement in this makes up for all of their Crimes Against Humanity…remember the first heading: George, Bill & Melinda, Sitting In A Tree, The One They’ll Hang From Yes, Indeed.

During my meditations, I ask to help everyone become more aware of The One Infinite Creator, I ask that we all become more aware of each other, ourselves, The Teachers, Jesus, The Holy Spirit, The Arch-Angels, Angels, our Spirit guides and the Lords of Light. I ask also to be more aware of the Synchronicities being shown to me, like the 666 and 1111 above.

Peace, Love & Blessings To All

Oliver

Proof Positive Johns Hopkins Is LYING About COVID-19 Death Toll Numbers

They show that nifty yellow line to make us think it’s getting worse…this one shows us that there are 1,147 less deaths than there were 30 seconds prior.

jh bs 5 30 20 1 20pm — **Johns Hopkins Fake COVID-19 Death Toll Numbers** , 1:20 pm EDT May 30th, 2020

jh bs 5 30 20 12 51 — **Johns Hopkins Fake COVID-19 Death Toll Numbers** , 12:50 pm EDT May 30th, 2020

The screen shot to the right was taken at 1:20 pm EDT May 30th, 2020. There have been 247 COVID-19 deaths in the US in the past 30 minutes, 214 in the UK, 111 covid deaths in Italy and France the numbers haven’t changed. I think someone at the Johns Hopkins Fake COVID-19 Death Toll Numbers center much have been reading this and decided to add a few to the UK and Italy.

Like the stock market after President Trump took office, the US covid-19 death toll continues to rise…oh my, what shall we do…for one, stop wearing those USELESS masks, go outside into the fresh air and sunshine, sunshine KILLS the virus…look at the Global Deaths number above 366,654…Synchronicity.

The screenshot to the left was taken May 30th, 2020 at 12:50 pm. As you can see, if you compare it to the last post on this post, taken on May 29th, 2020, yesterday, at 10:45 pm EDT, 1,127 COVID-19 deaths have occurred. Only 98 of those in the US…but ONCE AGAIN, NONE have occurred in the United Kingdom, Italy or France!

How are they able to prevent this “dreaded virus” from killing people? Could it be they’re not putting people on ventilators? Could it be that the hospitals aren’t getting $13,000 Dollars/$11,711 Euros for each COVID-19 patient they take in or $39,000 Dollars/$35,135 Euros for each COVID-19 patient they put on a ventilator, which is what is killing people. Are they not incentivized like the hospitals in the US??

I started taking screenshots of the global COVID-19 death toll numbers and they kept changing, but not the way you may think. This first shot taken today May 29th, 2020 at 5:36 pm EDT. It’s also here showing more falsities.

Johns Hopkins May 29th 5:36 pm — **Johns Hopkins May 29th, 2020 5:36 pm EDT**

I believe that Johns Hopkins is a COVID-19 manipulation machine. An hour and twenty minutes later. The Global COVID-19 death toll increased by 179 deaths. The US COVID-19 Death toll increased by 170! So only 9 other covid deaths on the entire planet!?

Johns Hopkins Fake COVID-19 Death Toll Numbers — **Johns Hopkins May 29th, 2020 6:51 pm EDT**

The UK, Italy and France COVID-19 death toll numbers stayed the same!! Why doesn’t the US start talking to Italy, France and the UK, since they seem to have it under control. Johns Hopkins would have you think the number just took a huge incline and the situation is getting worse…it’s not! When they can’t even get their own numbers straight or sync up with other fake news sources so us useless feeders can’t see what they’re doing or whose side they’re on.

It makes perfect sense though, Johns Hopkins is part of the Medical Industry…which needs what to stay in business?…wait for it…YOU, they need you and me and everyone else to be sick or make us think we are so then we go take one of their tests and get marked positive, with their false positive tests, which also probably infect you…so now you will get sick. This is a major Psy-Op they are part of.

This screenshot has the time and date in the lower right corner. In JUST 8 Minutes, 1,147 more Global COVID-19 Deaths occurred! But this time none of the COVID-19 deaths occurred in the US, UK, Italy or France. Johns Hopkins gave us a break!

The COVID-19 Death Toll Numbers Are Rolling Backwards

Look at this shot, taken within 1 minute to the one above, both taken May 29th, 2020 at 6:59 pm EDT. They show that nifty yellow line to make us think it’s getting worse…this one shows us that there are 1,147 less deaths than there were 30 seconds prior.

By the way, the numbers on here match the numbers of the screen shot I took at 6:51 pm above. I started getting the time and date in the screenshots so you can see that I’m not the one trying to pull a fast one…What could I possibly gain by fudging the numbers myself. The only thing I would like to gain is helping to awaken more people to the reality of our world. But wait, there’s more.

This shot taken at 7:06 pm on May 29th, 2020, 7 minutes after the previous shot, all the numbers are exactly the same.

**John Hopkins Fake COVID-19 Death Toll Numbers May 29th, 2020 10:37 pm EDT**

This next shot taken from the John Hopkins website Fake COVID-19 Death Toll Numbers May 29th, 2020 10:37 pm EDT. It was taken 3 hours and 31 minutes after the 7:06 pm shot.

That would give 1,639 more Global COVID-19 deaths. There were 99 more COVID-19 deaths in the US in that 3 hour and 31 minute time-span. Once again, the numbers remain the same in the UK, Italy and France. President Trump, I’m sure has a reason for keeping Dr Fauci and Dr Birx in his Administration, if not, they need to go…I think President Trump is going to give them all an expense-paid vacation to the tropical island of Cuba, where they’ll be stay at hotel GITMO…for a long time.

I’m going to keep checking the Johns Hopkins COVID-19 Fake Death Toll Numbers Map and adding to this post.

Peace, Love & Blessings!

RedPillian Ground Crew, Out!